Drug · JAK inhibitor · JAK inhibitor · Verified drug
Ruxolitinib (Jakafi) structure · mechanism
Ruxolitinib (Jakafi) 2D structure
- Role
- Drug
- Mechanism class
- JAK inhibitor
- Parent scaffold
- Pyrrolopyrimidine JAK core
- Structure source
- Catalog seed
Hand-written analysis
Mechanism
룩소리티닙은 JAK1/2 저해로 JAK-STAT를 막습니다. 골수섬유화·진성적혈구증가 등 골수증식와 일부 염증 적응이 있습니다. 감염·혈구감소를 모니터링합니다.
Medicinal chemistry
피롤로피리미딘입니다. 토파시티닙 등과 이소폼 선택이 다릅니다.
Indication · context
MPN·일부 이식편대숙주. /class 허브의 JAK 축입니다.
SMILES
N#CC[C@H](C1CCCC1)n2cc(c3c2ncnc3N)c4ccccc4Tags
Related compounds
External IDs · BioMoa
StructureMoa is a chemical-structure exploration tool. Structural similarity, clustering, and SAR relationships are intended for research exploration and do not establish shared potency, selectivity, safety, efficacy, or clinical performance.